It’s one of the most exciting sectors in the market right now. Picking the right company in this sector could help you generate triple-digit gains. But picking the wrong one could mean losing your shirt…
Some investors are too afraid to invest in biotech. You could easily lose a fortune investing in what looks like breakthrough research, only for the “life-changing” product to never reach consumers.
The trouble is, most folks don’t understand how hard it is to decipher drug development research results – from tests on lab mice all the way through the final Phase III clinical trials…
There’s no “secret trick” to finding, researching, and studying the businesses – drug developers, device makers, and technology companies. But it takes a massive amount of work.
That’s where my colleague Dave Lashmet comes in with his service, Venture Technology.
Joining Venture Technology is your way of essentially employing several personal research analysts to read through hundreds, even thousands, of pages of trial results, medical journals, and patent filings. Then, they distill the most important details and report them back to you.
Today, Dave is coming forward with the biggest market opportunity he has found in decades of writing about pharma… biotech… and the world’s greatest scientific discoveries.
According to Dave…
Based on my research, [one tiny] company’s world-changing drug is looking at a 2,000% long-term upside.
But only if you get in now. And the clock is ticking…
Within weeks, this story will hit the national press, and everyone from big investment banks to amateur traders will be pouring money into this stock.
But for now, it’s still almost a complete secret.
This opportunity isn’t for everyone. There’s always a fair amount of risk in tiny biotech companies.
But if you’re interested in learning how Dave’s strategy is an incredible way to add significant upside to your portfolio, click here for all the details.
Now on to this week’s Q&A… Please keep sending your questions, comments, and topic suggestions to [email protected].
Q: SEP IRAs allow a much higher contribution than a 401(k) plan and other retirement plans. I always read your advice about maximizing retirement plans but it doesn’t take into consideration SEP IRA. I wonder if maximizing your SEP IRA with 25% of your salary is a better strategy than contributing 15% to your SEP IRA and use the other 10% to invest on a non-retirement account. You are losing the ability to invest 10% of your salary in your retirement.
I have been a subscriber for of all your newsletters and then became an Alliance Member after receiving the invitation. Your recommendations have been great.
Thanks a lot. – J.A.
A: Thanks for being such an incredible supporter of Stansberry Research!
A simplified employee pension (also called a SEP or SEP-IRA), is an employer-funded retirement plan option for folks with a small business or those who are self-employed. We don’t want to get too into the weeds here, but here are some of the basics of a SEP…
An employer can contribute the lesser of 25% of compensation (limited to a compensation amount of $285,000) or $57,000 to a SEP. Those employer contributions don’t limit what you can put in your own IRA.
The amount of money contributed to the plan is up to the employer. If you’re self-employed, you can choose the amount you put in your SEP (with the limits we mentioned above). But employees don’t get to defer a percentage of their own salary into a SEP.
Q: Enjoyed your recent special report. As always very informative. You mentioned your thoughts on several artificial sweeteners, and I wanted to get your thoughts on one you didn’t mention, that being Stevia.
Thanks for your continued excellent health and investment guidance. – R.G.
A: Unlike other artificial sweeteners, stevia is an extract from the stevia plant… so it’s a more natural form of sweetener.
Unlike sugar, stevia seems to reduce blood-sugar spikes after meals and improves overall blood-sugar breakdown.
The problem with stevia, however, is blood pressure. Some research suggests that stevia lowers your blood pressure. This leads to dangerous levels if you’re already on blood pressure-lowering medication. Unfortunately, there aren’t enough studies yet for us to know just how dangerous this is.
Talk to your doctor before switching to stevia and monitor your blood pressure to know exactly how you’ll react to the sweetener.
Q: Have read numerous articles on the use of ultraviolet light to fight COVID-19, as well as other diseases. Was thinking of getting a UV lamp for a small apartment. Any thoughts appreciated. Thanks. – J.G.
A: Honestly, we’d say it’s probably a waste of money. The UV light needed to kill the coronavirus that causes COVID-19 is ultraviolet-C. This type of wavelength destroys DNA and leaves viruses and bacteria unable to reproduce. But it also destroys DNA in any cell… including humans. It can cause skin and eye damage, too.
The real issue here is how many viral particles are in your home. We know this coronavirus doesn’t live long on surfaces. It does stay in the air for a short time, but only if someone who is sick is coughing and spewing those virus particles into the air. So unless you have someone in the home who is actively sick or is a frontline worker (like a doctor or nurse) with a high likelihood of bringing it home, it seems like overkill.
What We’re Reading…
- Did you miss it? The key to wealth-altering gains in the stock market.
- Something different: The end of paper Social Security checks?
Here’s our health, wealth, and a great retirement,
Dr. David Eifrig and the Health & Wealth Bulletin Research Team
August 28, 2020